US2022185869A1PendingUtilityA1
Mammalian cell culture
Est. expiryJul 1, 2031(~5 yrs left)· nominal 20-yr term from priority
C12N 2523/00C12M 29/10C07K 16/2875C12N 5/0037C12N 5/0682C12N 2500/02C07K 16/00C07K 1/14C12N 2500/32C12N 2510/02C07K 2317/14C12P 21/02C12P 21/00C12N 5/0604C12N 2500/99
80
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides a method for culturing mammalian cells. The method provides greater control over cell growth to achieve high product titer cell cultures.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of arresting cell growth in a mammalian cell culture expressing a recombinant protein comprising:
establishing a mammalian cell culture in a serum-free culture medium in a bioreactor; inducing cell growth-arrest by perfusion with a serum-free perfusion medium having an L-asparagine concentration of 5 mM or less; maintaining the mammalian cells in a growth-arrested state by perfusion with a serum-free perfusion medium having an L-asparagine concentration of 5 mM or less.
2 . A method of limiting a mammalian cell culture expressing a recombinant protein at a desired packed cell volume (PCV) comprising:
establishing a mammalian cell culture in a serum-free culture medium in a bioreactor, inducing cell growth-arrest by perfusion with a serum-free perfusion medium having an L-asparagine concentration of 5 mM or less,
maintaining the mammalian cells in a growth-arrested state by perfusion with a serum-free perfusion medium having an L-asparagine concentration of 5 mM or less.
3 . The method of claim 2 , further comprising a temperature shift, wherein the temperature is lowered from between 35° C. and 38° C. to between 30° C. and 34° C.
4 . The method of claim 2 , wherein the temperature shift occurs at the transition between a growth phase and a production phase.
5 . The method of claim 2 , wherein the temperature shift occurs during a production phase.
6 . The method of claim 2 , further comprising a temperature shift, wherein the growth phase occurs at a temperature from about 35° C. to about 38° C. and the production phase occurs at a temperature from about 30° C. to about 34° C.
7 . The method of claim 2 , wherein the desired PCV is 35% or less.
8 . A method of culturing mammalian cells expressing a recombinant protein comprising:
establishing a mammalian cell culture in a serum-free culture medium in a bioreactor; growing the mammalian cells during a growth phase and supplementing the culture medium with bolus feeds of a serum-free feed medium, and maintaining the mammalian cells during a production phase by perfusion with a serum-free perfusion medium, wherein the packed cell volume during the production phase is less than or equal to 35%.
9 . The method of claim 8 , wherein perfusion begins when the cells have reached a production phase.
10 . The method of claim 8 , further comprising inducing cell growth-arrest by perfusion with a serum-free perfusion medium having an L-asparagine concentration of 5 mM or less.
11 . The method of claim 8 , wherein the packed cell volume is less than or equal to 30%.
12 . The method of claim 8 , wherein the viable cell density of the mammalian cell culture at a packed cell volume less than or equal to 35% is 10×10 6 viable cells/ml to 80×10 6 viable cells/ml.
13 . The method of claim 8 , further comprising a temperature shift, wherein the temperature is lowered from between 35° C. and 38° C. to between 30° C. and 34° C.
14 . The method of claim 8 , wherein the temperature shift occurs at the transition between a growth phase and a production phase.
15 . The method of claim 8 , wherein the temperature shift occurs during a production phase.
16 . The method of claim 8 , further comprising a temperature shift, wherein the growth phase occurs at a temperature from about 35° C. to about 38° C. and the production phase occurs at a temperature from about 30° C. to about 34° C.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.